Genomic Medicine, Data Modeling and Clinical Trials: 3 factors biopharma leaders must understand

A genome is essentially a database of a living thing — which makes translating this precise information a powerful approach for guiding drug development and bringing treatments to market faster. For instance, consider the role of genomics in clinical trials in the emerging field of immuno-oncology. “Many of the trials in immuno-oncology include a genomically targeted therapy,” says Anita Nelsen, Head of PAREXEL® Genomic Medicine Services. With advanced analytics and predictive data modeling, Nelsen says, “researchers are changing the design of clinical trials to enable patients to be selected based on the genome of their tumor and to help streamline patient recruiting and decision-making during the clinical trial.” As we move toward more targeted treatments for cancer there are key questions to consider.  For example, what’s the mutational burden across…


Link to Full Article: Genomic Medicine, Data Modeling and Clinical Trials: 3 factors biopharma leaders must understand

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!